Number of antibiotic dispensations potentially linked with IBD development

Higher cumulative exposure to systemic antibiotic therapy may be associated with higher risk for the development of inflammatory bowel disease, according to research published in Lancet Gastroenterology & Hepatology.
Jonas F. Ludvigsson, MD, of the department of medical epidemiology and biostatistics at Karolinska Institutet in Sweden, and colleagues wrote that learning how environmental and other factors impact the development of IBD is critical.
“Globally, rates of IBD are rising, particularly in areas undergoing rapid economic development,” they wrote. “Since these

Source link

Related posts

People with depression are more likely to develop Crohn's disease


NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma


Resistance did not affect SVR rates in trials of Vosevi for HCV


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World